Literature DB >> 18059457

24-h uric acid excretion and the risk of kidney stones.

G C Curhan1, E N Taylor.   

Abstract

There is uncertainty about the relation between 24-h urinary uric acid excretion and the risk of calcium oxalate nephrolithiasis. In addition, the risk associated with different levels of other urinary factors needs clarification. We performed a cross-sectional study of 24-h urine excretion and the risk of kidney stone formation in 3350 men and women, of whom 2237 had a history of nephrolithiasis. After adjusting for other urinary factors, urinary uric acid had a significant inverse association with stone formation in men, a marginal inverse association with risk in younger women, and no association in older women. The risk of stone formation in men and women significantly rose with increasing urine calcium and oxalate, and significantly decreased with increasing citrate and urine volume, with the change in risk beginning below the traditional normal thresholds. Other urinary factors were also associated with risk, but this varied by age and gender. Our study does not support the prevailing belief that higher urine uric acid excretion increases the risk for calcium oxalate stone formation. In addition, the current definitions of normal levels for urinary factors need to be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059457     DOI: 10.1038/sj.ki.5002708

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  99 in total

1.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

Review 2.  Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.

Authors:  Omotayo Arowojolu; David S Goldfarb
Journal:  J Nephrol       Date:  2014-04-01       Impact factor: 3.902

3.  Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate.

Authors:  John Knight; Dean G Assimos; Michael F Callahan; Ross P Holmes
Journal:  Metabolism       Date:  2010-10-30       Impact factor: 8.694

Review 4.  Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.

Authors:  David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

5.  Reproducibility of urinary biomarkers in multiple 24-h urine samples.

Authors:  Qi Sun; Kimberly A Bertrand; Adrian A Franke; Bernard Rosner; Gary C Curhan; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2016-11-09       Impact factor: 7.045

6.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

7.  Disentangling the Relationships Between the Renin-Angiotensin-Aldosterone System, Calcium Physiology, and Risk for Kidney Stones.

Authors:  Omar Bayomy; Sarah Zaheer; Jonathan S Williams; Gary Curhan; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

8.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

9.  Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

Authors:  Carla G Monico; Adam Weinstein; Zhirong Jiang; Audrey L Rohlinger; Andrea G Cogal; Beth B Bjornson; Julie B Olson; Eric J Bergstralh; Dawn S Milliner; Peter S Aronson
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

Review 10.  Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Authors:  Ross P Holmes; John Knight; Dean G Assimos
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.